Docoh
Loading...

ATXI Avenue Therapeutics

192 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
DEF 14A
ATXI Avenue Therapeutics Inc
23 Nov 21
Definitive proxy
4:07pm
10-Q
2021 Q3
ATXI Avenue Therapeutics Inc
15 Nov 21
Quarterly report
9:02am
424B5
ATXI Avenue Therapeutics Inc
10 Nov 21
Prospectus supplement for primary offering
5:25pm
8-K
ATXI Avenue Therapeutics Inc
10 Nov 21
Entry into a Material Definitive Agreement
5:22pm
424B5
ATXI Avenue Therapeutics Inc
9 Nov 21
Prospectus supplement for primary offering
5:14pm
8-K
ATXI Avenue Therapeutics Inc
4 Nov 21
Termination of a Material Definitive Agreement
4:08pm
8-K
ATXI Avenue Therapeutics Inc
25 Oct 21
Other Events
9:01am
EFFECT
ATXI Avenue Therapeutics Inc
4 Oct 21
Notice of effectiveness
12:15am
CORRESP
ATXI Avenue Therapeutics Inc
30 Sep 21
Correspondence with SEC
8:00pm
UPLOAD
ATXI Avenue Therapeutics Inc
29 Sep 21
Letter from SEC
8:00pm
S-3
ATXI Avenue Therapeutics Inc
28 Sep 21
Shelf registration
4:06pm
8-K
ATXI Avenue Therapeutics Inc
21 Sep 21
Other Events
8:31am
4
Vazzano Joseph Walter
15 Sep 21
AVENUE THERAPEUTICS / Joseph Walter Vazzano ownership change
4:03pm
8-K
ATXI Avenue Therapeutics Inc
3 Sep 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
ATXI Avenue Therapeutics Inc
1 Sep 21
Other Events
8:30am
8-K
ATXI Avenue Therapeutics Inc
27 Aug 21
Other Events
9:18am
10-Q
2021 Q2
ATXI Avenue Therapeutics Inc
16 Aug 21
Quarterly report
11:17am
8-K
ATXI Avenue Therapeutics Inc
29 Jul 21
Other Events
4:01pm
8-K
ATXI Avenue Therapeutics Inc
14 Jul 21
Other Events
8:00pm
8-K
ATXI Avenue Therapeutics Inc
14 Jun 21
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
9:00am